Nevirapine MMF, MPA 640

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 dose
200 mg BID x 43 doses
Drug 1 effect

No significant change

Drug 2
Drug 2 dose
500 mg BID x 8 weeks
Drug 2 effect

Not studied

Management

Use alternative agents

Import ID
640